Holmes BioPharma: Omaha Facility Awarded First Contract

Holmes Biopharma, Inc. (OTCBB: HLMB) announces that its newly opened clinical research facility in Omaha, Nebraska has been awarded a Phase 1 clinical research contract from a major (Top-10) pharmaceutical company.
MORE ON THIS TOPIC